Carlos Escasena
Neurology · Coral Gables, FLNPI 1770852410
Payments from drug & device makers
Across 506 payments — averaging $2440.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$721K
- AbbVie$443K
- Amgen$34K
- Biohaven Pharmaceutical Holding Company Ltd.$13K
- Biohaven Pharmaceuticals, Inc.$9K
- Lilly USA, LLC$8K
- plus $7K from 17 others
Across 1 payment — averaging $180,990 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$181K
What the payments were for
- Consulting fees$4,3253%
- Speaking & faculty fees$133,00591%
- Travel & lodging$80%
- Food & beverage$8,2486%
- Education$1300%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 4 | $721,000 |
| AbbVie(2 entities) | 300 | $443,147 |
| Amgen | 54 | $33,619 |
| Biohaven Pharmaceutical Holding Company Ltd. | 24 | $13,165 |
| Biohaven Pharmaceuticals, Inc. | 26 | $9,488 |
| Lilly USA, LLC | 26 | $7,971 |
| Pfizer | 5 | $4,734 |
| Teva Pharmaceuticals USA, Inc. | 15 | $429 |
| Scilex Pharmaceuticals Inc. | 16 | $364 |
| Lundbeck LLC | 8 | $223 |
| Upsher-smith Laboratories LLC | 10 | $195 |
| Microvention, Inc. | 1 | $133 |
| UCB, Inc. | 1 | $126 |
| Novartis | 4 | $87 |
| Zyla Life Sciences, Inc. | 4 | $67 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Bausch Health US, LLC | 1 | $25 |
| Eisai Inc. | 1 | $22 |
| Assertio Therapeutics, Inc. | 1 | $20 |
| Avanir Pharmaceuticals, Inc. | 1 | $20 |
| Biogen | 1 | $18 |
| Hikma Pharmaceuticals USA | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$69,541
- AIMOVIG$33,032
- NURTEC ODT$26,658
- QULIPTA$14,113
- WEB Aneurysm Embolization System$133
- Nayzilam$126
How this compares
$1,234,908 in reported general payments places this provider in the 95th percentile of 1,434 neurology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| QuliptaAtogepant | 24 | $25,271 |
| Aimovig AutoinjectorErenumab-Aooe | 20 | $14,496 |
| Ajovy AutoinjectorFremanezumab-Vfrm | 16 | $11,531 |
| Sumatriptan Succinate | 14 | $1,381 |
| RizatriptanRizatriptan Benzoate | 23 | $192 |
| Bupropion XlBupropion Hcl | 12 | $90 |
| Gabapentin | 12 | $83 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieQulipta | $443,147 | $25,27124 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,434 neurology providers in Florida.
Other neurology in Coral Gables
- Mark GoldsteinAtlantis$36.1M
- Derrick RobertsonTampa$27.6M
- Beth SafirsteinHallandale Beach$25.7M
- Michael PfefferMiami$24.5M
- Mark BrodyDelray Beach$20.5M
- Paayal PatelWest Palm Beach$17.3M
- Wendy BondFort Myers$14.7M
- William HoneycuttMaitland$14.1M
- Julie SchwartzbardAventura$13.6M
- Rekha GandhiWinter Park$13.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.